Alzheimer’s disease (AD) is the most common form of dementia, affecting more than five million people in the US alone; it’s also the sixth leading cause of deaths in the country. Here’s a closer look at those Alzheimer’s disease treatment stocks. First on our Alzheimer’s disease treatment stocks list is Actinogen Medical. Actinogen Medical (ASX:ACW) Market cap: AUD$38.11 million; current share price: AUD$0.05. Middle of the pack on our Alzheimer’s disease treatment stocks list is Axsome Therapeutics. Axsome Therapeutics (NASDAQ:AXSM)Market cap: $170.18 million; current share price: $1.58 Closing out our Alzheimer’s disease treatment stocks list is vTv Therapeutics. vTv Therapeutics (NASDAQ:VTVT)Market cap: $191.62 million; current share price: $5.84.
Read the Full Story at investingnews.com
5 Alzheimer’s Disease Treatment Stocks
More from BusinessMore posts in Business »
- Biogen Stays the Wrong Course After a Key Drug Failure
- What Happened? Alzheon Leaves IPO on the Table for the Second Time | Biospace
- Biogen Inks Two Deals to Make Drugs for Neurological Diseases | NASDAQ
- AC Immune inks $1.7bn deal with Lilly, strategic partnership with WuXi | Outsourcing Pharma
- BioXcel Announces Positive Data On Senile Dementia Of Alzheimer’s Type; Stock Up | NASDAQ